Riskpilot← Back to searchSign inGet full accessRADU GYN.MED AB
ABActiveOrg 5568723992Edbovägen 59Medical specialists activities · NACE 8622Est. 20111 employees
Revenue 2024
SEK 1,6M
-1% vs 2023
EBITDA margin
28.1%
-9% vs 2023
Equity ratio
45.7%
Financial strength
Net profit 2024
SEK 347K
-10% vs 2023
| Revenue | SEK 1,6M | -1% |
| EBITDA | SEK 436K | -9% |
| Net profit | SEK 347K | -10% |
| Total assets | SEK 887K | -13% |
| Equity | SEK 406K | -12% |
| Employees | 1 | — |
Legal name
RADU GYN.MED AB
Org number
5568723992
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
19 november 2011
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Vasilcanu, Radu
Company purpose
Bolaget ska bedriva läkarkonsultverksamhet inom och utanför Sverige samt därmed förenlig verksamhet,
Address
Edbovägen 59
Email
raduvasilcanu@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 648 | 1 795 | 1 601 | 1 562 | 1 553 |
| Staff expenses | — | — | −1 035 | −1 037 | −791 |
| EBITDA | 517 | 566 | 498 | 479 | 436 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 517 | 566 | 498 | 479 | 436 |
| Net financials | — | — | 0 | 8 | 0 |
| Profit before tax | 517 | 566 | 498 | 487 | 437 |
| Tax | −115 | −117 | −103 | −100 | −90 |
| Net profit | 402 | 449 | 395 | 387 | 347 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 140 | 1 381 | 1 137 | 1 020 | 887 |
| Equity | 452 | 502 | 447 | 459 | 406 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 688 | 879 | 690 | 561 | 482 |
| Total debt | 688 | 879 | 690 | 561 | 482 |
EBITDA margin
28.1%
This company
15.8%
Market median
+78% vs market
20202024
Equity ratio
45.7%
This company
38.2%
Market median
+20% vs market
20202024
Return on equity
85.5%
This company
18.4%
Market median
+365% vs market
20202024
Net profit margin
22.3%
This company
8.1%
Market median
+175% vs market
20202024
Asset turnover
1.75×
This company
1.12×
Market median
+56% vs market
20202024
Debt / equity
1.19×
This company
0.62×
Market median
-92% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of RADU GYN.MED AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Radu Vasilcanu | Chairman | 0 companies |
| Daiana Camina Vasilcanu | Board of Directors | 0 companies |
| Raluca-Maria Berggren | Deputy Board Member | 0 companies |